| Literature DB >> 34093351 |
Senthilkumar Sadhasivam1, Suresh Alankar2, Raj Maturi3, Amy Williams4, Ramana V Vishnubhotla1,5, Sepideh Hariri6, Mayur Mudigonda7, Dhanashri Pawale1, Sangeeth Dubbireddi8, Senthil Packiasabapathy1, Peter Castelluccio9, Chithra Ram10, Janelle Renschler1, Tracy Chang11, Balachundhar Subramaniam6.
Abstract
Background: Meditation is gaining recognition as a tool to impact health and well-being. Samyama is an 8-day intensive residential meditation experience conducted by Isha Foundation requiring several months of extensive preparation and vegan diet. The health effects of Samyama have not been previously studied. The objective was to assess physical and emotional well-being before and after Samyama participation by evaluating psychological surveys and objective health biomarkers.Entities:
Keywords: Isha; Samyama; anxiety; biomarkers; depression; meditation; mindfulness; triglycerides
Year: 2021 PMID: 34093351 PMCID: PMC8170079 DOI: 10.3389/fpsyg.2021.659667
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1Samyama retreat timeline.
Figure 2CONSORT diagram.
Validated surveys and scoring systems.
| Depression | CES-D-10 Depression Scale (10 q) | 0–30 | Andresen et al., |
| Emotional distress/anxiety | Emotional Distress/Anxiety Short Form (8 q) | 8–40 | Pilkonis et al., |
| Mindfulness | Mindful Attention Awareness Scale (5 q) | 1–6 | Brown and Ryan, |
| Joy | Joy subscale of the Dispositional Positive Emotion Scales (6 q) | 6–42 | Shioata et al., |
| Vitality | Subjective Vitality Scale (6 q) | 7–42 | Bostic et al., |
| Resilience | Brief Resilience Scale (6 q) | 6–30 | Smith et al., |
CES, Center for Epidemiological Studies; q, questions.
Baseline demographics.
| Race | 0.10 | ||
| Asian (Far East) | 9 (5%) | 1 (2%) | |
| Asian (Indian) | 125 (64%) | 46 (78%) | |
| Asian (Middle Eastern) | 1 (0.5%) | 1 (2%) | |
| Black (African American) | 2 (1%) | 0 | |
| Hispanic | 6 (2%) | 0 | |
| White, non-hispanic | 41 (21%) | 6 (10%) | |
| Mixed race (Asian-white) | 2 (1%) | 0 | |
| Mixed race (Other) | 3 (2%) | 0 | |
| Other | 4 (2%) | 0 | |
| Prefer not to answer | 1 (0.5%) | 0 | |
| Missing | 1 (0.5%) | 5 (9%) | |
| Sex | 0.92 | ||
| Female | 110 (56%) | 31 (53%) | |
| Male | 85 (44%) | 24 (41%) | |
| Unknown | 0 | 4 (7%) | |
| Vegan diet | 48 (25%) | 4 (7%) | |
| Age (years) | 42.2 ± 11.6 | 40.4 ± 9.8 | 0.30 |
| Weight (kg) | 63.0 ± 11.3 | 72.5 ± 14.0 | |
| Previous Samyama practice | 43 (22.1%) | n/a | n/a |
Bolded values are significantly different (P < 0.05).
Figure 3Improvements in depression and anxiety with Samyama: change in (A) depression and (B) anxiety across assessment timepoints separated by those with and without scores above the clinical cutoff at baseline for each measure. Dotted line indicates clinical cutoff for relevant measure. Depression was assessed with the 10-item Center for Epidemiological Studies Depression scale (CESD-10). Anxiety was assessed with the PROMIS Emotional Distress Anxiety—Short Form 8a.
Figure 4Improvements in mindfulness, joy, vitality, and resilience with Samyama: change in scores across assessment timepoints for current state of (A) mindfulness (State Mindful Attention Awareness Scale), (B) joy (Joy Subscale of the Dispositional Positive Emotion Scale), (C) vitality (Subjective Vitality Scale), and (D) resilience (The Brief Resilience Scale).
Diet and meditation practices.
| Vegan diet | Control | 2 | 6/41 (14.6%) |
| Participant | 176/195 (90.3%) | ||
| Samyama practice | Participant | 2 | 42/195 (21.5%) |
| 3 | 189/195 (96.9%) | ||
| 4 | 155/195 (79.5%) | ||
| Breath watching | 2 | n/a | |
| 3 | 192/195 (98.5%) | ||
| 4 | 181/195 (92.8%) |
Figure 5Comparisons of blood biomarkers in Samyama participants and controls: blood biomarker data was analyzed for four timepoints (T1 = baseline; T2 = immediately before retreat; T3 = immediately after retreat; T4 = 3 months after retreat). Biomarkers measured were: (A) Hemoglobin, (B) HbA1c, (C) CRP, (D) HDL, (E) LDL, (F) Cholesterol, and (G) Triglycerides. Compared with the controls, the participants had 2–3-fold lower CRP levels at all timepoints (adjusted P < 0.02). At T2, participants had significantly improved HbA1c (0.66 g/dL, adjusted P = 0.002) and HDL (1.4 mmol/L, adjusted P = 0.02) compared with controls (0.77 g/dL and 1.09 mmol/L, respectively). * Denotes statistical significance comparing participants vs. controls at a given timepoint. An adjusted P < 0.05 was considered significant. Chol, cholesterol; CRP, C-reactive protein; Hb, hemoglobin; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.